CC
CVS icon

ClearArc Capital’s CVS Health CVS Stock Holding History

ClearArc Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1.03M Sell
13,882
-5,697
-29% -$400K 0.4% 61
2019
Q3 		$1.24M Buy
19,579
+191
+1% +$11.3K 0.36% 65
2019
Q2 		$1.06M Sell
19,388
-2,321
-11% -$125K 0.31% 74
2019
Q1 		$1.17M Sell
21,709
-483
-2% -$29.8K 0.31% 74
2018
Q4 		$1.45M Sell
22,192
-4,151
-16% -$310K 0.44% 55
2018
Q3 		$2.07M Buy
26,343
+321
+1% +$22.9K 0.27% 90
2018
Q2 		$1.68M Buy
26,022
+135
+0.5% +$8.9K 0.24% 95
2018
Q1 		$1.61M Buy
25,887
+70
+0.3% +$5.02K 0.24% 99
2017
Q4 		$1.87M Sell
25,817
-331
-1% -$24.1K 0.25% 90
2017
Q3 		$2.13M Buy
26,148
+1,158
+5% +$91.6K 0.32% 74
2017
Q2 		$2.01M Sell
24,990
-89
-0.4% -$7.03K 0.32% 75
2017
Q1 		$1.97M Sell
25,079
-846
-3% -$67.5K 0.33% 76
2016
Q4 		$2.05M Sell
25,925
-220
-0.8% -$17.8K 0.37% 70
2016
Q3 		$2.33M Buy
26,145
+74
+0.3% +$6.99K 0.44% 56
2016
Q2 		$2.5M Sell
26,071
-723
-3% -$72.1K 0.49% 57
2016
Q1 		$2.78M Sell
26,794
-290
-1% -$28.2K 0.59% 42
2015
Q4 		$2.65M Sell
27,084
-185
-0.7% -$18.1K 0.55% 43
2015
Q3 		$2.63M Sell
27,269
-4,518
-14% -$475K 0.55% 42
2015
Q2 		$3.33M Buy
31,787
+3,947
+14% +$403K 0.61% 37
2015
Q1 		$2.87M Sell
27,840
-809
-3% -$81.9K 0.59% 37
2014
Q4 		$2.76M Buy
28,649
+530
+2% +$46.7K 0.56% 39
2014
Q3 		$2.24M Buy
28,119
+504
+2% +$39.7K 0.51% 47
2014
Q2 		$2.08M Sell
27,615
-1,614
-6% -$122K 0.48% 54
2014
Q1 		$2.19M Buy
29,229
+1,965
+7% +$139K 0.54% 46
2013
Q4 		$1.95M Sell
27,264
-15,989
-37% -$1.03M 0.51% 51
2013
Q3 		$2.46M Sell
43,253
-18,000
-29% -$1.07M 0.69% 33
2013
Q2 		$3.5M Buy
+61,253
New +$3.55M 0.94% 23

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ClearArc Capital's CVS Position: Q4 2019 in Review

ClearArc Capital reduced its CVS Health (CVS) stake by 29% in Q4 2019, selling an estimated $400K and leaving 13,882 shares worth $1.03M. The position accounts for 0.4% of the portfolio, ranked #61.

ClearArc Capital first reported a position in CVS in Q2 2013 and has held it in 27 quarters since. The position peaked at $3.5M in Q2 2013. 1,844 funds tracked by Wall St. Rank hold CVS as of Q4 2019.

  • ClearArc Capital held 13,882 shares of CVS Health worth $1.03M as of Q4 2019.
  • ClearArc Capital sold 5,697 CVS Health shares in Q4 2019, an estimated $400K.
  • CVS Health made up 0.4% of ClearArc Capital's portfolio in Q4 2019, its #61 holding.
  • ClearArc Capital first reported a position in CVS Health in Q2 2013 and has held it in 27 quarters since.
  • ClearArc Capital's CVS Health position peaked at $3.5M in Q2 2013.
  • 1,844 funds tracked by Wall St. Rank held CVS Health as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.